Dr. Mario Vukic , MD
Specialist • Hackensack, NJ
211 Essex St, Suite 202
Hackensack, NJ 076013231
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 1, 2006; this date does not establish years in practice.
-
Published CMS data list 1,960 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 786 service units.
- 95886 — Needle measurement of electrical activity in arm or leg muscles, complete study: 262 service units.
- 99213 — Established patient outpatient office visit: 250 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 15 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,536 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Memantine Hcl — 334 prescription fills, including refills.
- Gabapentin — 304 prescription fills, including refills.
- Donepezil Hcl — 165 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 52 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Specialist in Hackensack, NJ (2024, 13 clinicians with data). Median for this group: 1,329. Middle half: 893 to 5,250.
More Medicare Part B services than 60% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: 1,216. Middle half: 379 to 3,335.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,526 in 2020 to 1,960 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
211 Essex St
Suite 202
Hackensack, NJ 076013231
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: The Medical Group Of New Jersey. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
State University Of New York At Stony Brook, School Of Medicine
1998
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
676 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $317,254 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $238,721 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
4,895 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$10,541,855 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $149,351.88 across 229 records.
By nature of payment (3 largest of 4)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $118,071.00 across 46 records.
- Travel and Lodging: $17,231.90 across 82 records.
- Consulting Fee: $8,280.00 across 3 records.
Reporting-company totals (3 largest of 15)
- ARGENX US, INC.: $60,977.12 across 88 records.
- UCB, Inc.: $37,475.34 across 43 records.
- Amgen Inc.: $21,108.83 across 27 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
28 years (graduated 1998)
CMS Doctors and Clinicians data list 1998 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Vukic has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Vukic as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Hackensack and New Jersey
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Specialist in Hackensack, NJ (2024, 13 clinicians with data). Median for this group: 1,329. Middle half: 893 to 5,250.
More Medicare Part B services than 60% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: 1,216. Middle half: 379 to 3,335.
Medicare-allowed amount
A higher Medicare-allowed amount than 75% of clinicians listed under Specialist in Hackensack, NJ (2024, 13 clinicians with data). Median for this group: $213,186. Middle half: $83,151 to $317,254.
A higher Medicare-allowed amount than 85% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: $102,518. Middle half: $34,749 to $219,553.
Paid by Medicare
A higher Medicare payment amount than 75% of clinicians listed under Specialist in Hackensack, NJ (2024, 13 clinicians with data). Median for this group: $160,839. Middle half: $60,124 to $238,721.
A higher Medicare payment amount than 85% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: $77,614. Middle half: $27,413 to $166,417.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Specialist in Hackensack, NJ (2024, 11 clinicians with data). Median for this group: 1,398. Middle half: 697 to 2,734.
More Part D prescriptions than 80% of clinicians listed under Specialist in New Jersey (2024, 365 clinicians with data). Median for this group: 645. Middle half: 134 to 1,745.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Specialist in Hackensack, NJ (2024, 11 clinicians with data). Median for this group: $547,226. Middle half: $130,238 to $1,063,866.
A higher Part D drug cost than 95% of clinicians listed under Specialist in New Jersey (2024, 365 clinicians with data). Median for this group: $63,715. Middle half: $4,163 to $333,079.
30 active clinicians are listed under Specialist with a practice address in Hackensack, NJ (1,641 in New Jersey).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Hackensack
20% of these 30 clinicians have the CMS telehealth indicator.
40% of these 30 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 28% from 1,526 in 2020 to 1,960 in 2024.
- 2020: 1,526
- 2021: 1,800
- 2022: 1,883
- 2023: 2,018
- 2024: 1,960
-
Medicare-allowed amount
Medicare-allowed amount increased 27% from $249,129 in 2020 to $317,254 in 2024.
- 2020: $249,129
- 2021: $347,920
- 2022: $349,025
- 2023: $339,163
- 2024: $317,254
-
Paid by Medicare
Paid by Medicare increased 23% from $193,550 in 2020 to $238,721 in 2024.
- 2020: $193,550
- 2021: $274,164
- 2022: $272,106
- 2023: $260,889
- 2024: $238,721
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 29% from 1,972 in 2020 to 2,536 in 2024.
- 2020: 1,972
- 2021: 2,105
- 2022: 2,187
- 2023: 2,544
- 2024: 2,536
-
30-day fills
30-day fills increased 52% from 3,225 in 2020 to 4,895 in 2024.
- 2020: 3,225
- 2021: 3,513
- 2022: 3,810
- 2023: 4,516
- 2024: 4,895
-
Part D drug cost
Part D drug cost increased 372% from $2,232,605 in 2020 to $10,541,855 in 2024.
- 2020: $2,232,605
- 2021: $2,793,005
- 2022: $5,080,471
- 2023: $7,257,686
- 2024: $10,541,855
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $299.53 in 2021 to $149,351.88 in 2025.
- 2021: $299.53
- 2022: $6,906.37
- 2023: $45,789.36
- 2024: $107,504.06
- 2025: $149,351.88
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 229 records totaling $149,351.88.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Rystiggo | General | $4,800.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $3,885.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $3,885.00 |
| Amgen Inc. |
Consulting Fee
Cash or cash equivalent
|
UPLIZNA | General | $3,850.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Rystiggo | General | $3,500.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Rystiggo | General | $3,500.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Rystiggo | General | $3,500.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Zilbrysq | General | $3,500.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Rystiggo | General | $3,500.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Zilbrysq | General | $3,500.00 |
| Amgen Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $3,300.00 |
| Amgen Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $3,300.00 |
| Amgen Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $3,300.00 |
| ARGENX US, INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
VYVGART HYTRULO | General | $3,000.00 |
| ARGENX US, INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
VYVGART | General | $3,000.00 |
| ARGENX US, INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
VYVGART | General | $3,000.00 |
| ARGENX US, INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
VYVGART | General | $3,000.00 |
| ARGENX US, INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
VYVGART | General | $3,000.00 |
| ARGENX US, INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
VYVGART | General | $3,000.00 |
| ARGENX US, INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
VYVGART | General | $3,000.00 |
| ARGENX US, INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
VYVGART | General | $3,000.00 |
| ARGENX US, INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
VYVGART | General | $3,000.00 |
| ARGENX US, INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
VYVGART | General | $3,000.00 |
| AstraZeneca Pharmaceuticals LP |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ULTOMIRIS | General | $2,957.50 |
| Amgen Inc. |
Consulting Fee
Cash or cash equivalent
|
UPLIZNA | General | $2,750.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
786 | 382 | $578.52 | $139.54 |
|
95886
Needle measurement of electrical activity in arm or leg muscles, complete study
|
262 | 144 | $396.00 | $106.37 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
250 | 157 | $450.00 | $99.70 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
148 | 148 | $800.00 | $181.97 |
|
95813
Measurement of brain wave activity (eeg), 61-119 minutes
|
113 | 113 | $1500.00 | $501.21 |
|
95910
Nerve conduction, 7-8 studies
|
67 | 66 | $2250.00 | $191.01 |
|
93886
Complete ultrasound of within the brain blood flow
|
65 | 64 | $600.00 | $307.29 |
|
93880
Ultrasound of both sides of head and neck blood flow
|
64 | 63 | $650.00 | $169.41 |
|
95911
Nerve conduction, 9-10 studies
|
58 | 58 | $965.92 | $233.20 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
33 | 14 | $350.00 | $83.20 |
|
93880
Ultrasound of both sides of head and neck blood flow
|
29 | 29 | $550.00 | $39.73 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
25 | 14 | $812.88 | $149.00 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
21 | 21 | $507.16 | $121.84 |
|
95909
Nerve conduction, 5-6 studies
|
20 | 19 | $1540.00 | $148.45 |
|
93886
Complete ultrasound of within the brain blood flow
|
19 | 12 | $300.00 | $48.63 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Memantine Hcl | Memantine Hcl | 334 | 25,563 | $12,594.64 | 95 |
| Gabapentin | Gabapentin | 304 | 19,355 | $6,671.96 | 91 |
| Donepezil Hcl | Donepezil Hcl | 165 | 13,254 | $2,149.65 | 46 |
| Gamunex-C | Immune Globul G/Gly/Iga Avg 46 | 155 | 3,841 | $1,911,934.55 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 143 | 9,546 | $5,562.11 | 39 |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 101 | 7,950 | $14,098.52 | 33 |
| Pregabalin | Pregabalin | 94 | 4,957 | $2,468.85 | 25 |
| Levetiracetam | Levetiracetam | 77 | 5,647 | $2,070.02 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 59 | 3,681 | $1,908.81 | 16 |
| Sodium Chloride | 0.9 % Sodium Chloride | 51 | 1,917 | $207.77 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 49 | 3,300 | $384.31 | 16 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 45 | 2,058 | $3,660.11 | — |
| Vyvgart Hytrulo | Efgartigimod-Hyaluronidas-Qvfc | 45 | 1,233 | $2,584,337.46 | 12 |
| Vyvgart | Efgartigimod Alfa-Fcab | 44 | 1,265 | $2,530,816.15 | — |
| Zolpidem Tartrate | Zolpidem Tartrate | 41 | 1,230 | $205.91 | — |
| Divalproex Sodium | Divalproex Sodium | 40 | 2,085 | $319.97 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 38 | 2,940 | $603.05 | 11 |
| Primidone | Primidone | 36 | 2,730 | $1,069.67 | 16 |
| Prednisone | Prednisone | 33 | 1,366 | $176.64 | — |
| Rivastigmine | Rivastigmine Tartrate | 32 | 2,136 | $2,595.84 | 11 |
| Diphenhydramine Hcl | Diphenhydramine Hcl | 32 | 547 | $66.68 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 32 | 1,370 | $451.96 | — |
| Ultomiris | Ravulizumab-Cwvz | 30 | 1,467 | $1,653,599.86 | — |
| Amantadine | Amantadine Hcl | 29 | 1,980 | $1,329.39 | 12 |
| Lacosamide | Lacosamide | 29 | 1,465 | $956.81 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEUROLOGY
I20050627000020
NJ
2567407919
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
The Medical Group Of New Jersey
211 Essex St, Hackensack, NJ 076013245
Phone: 2014881515
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Psychiatry & Neurology - Neurology
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated March 01, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Specialists in Hackensack
- Dr. Marson Davidson, MD
- Dr. Michael Silverstein, MD
- Dr. Kevin Basralian, MD
- Dr. Allen Sapadin, MD
- Dr. Anthony Marquinez, MD
- Dr. Gregory Rauscher, MD
More public profiles in New Jersey
Directory navigation, in NPI number order.
- Jennifer Mojica-Itidiare, DO Internal Medicine · Stratford
- Shamik Chakraborty, MD Neurological Surgery · Freehold
- Sookie Hwang, DDS Dentist - General Practice · Riverdale
- Azza Abdel Hak, MD Internal Medicine - Nephrology · Voorhees
- Megan Clinthorne, DPT Physical Therapist · Cherry Hill
- Ihuoma Ottih, APN-C Nurse Practitioner - Adult Health · Magnolia
- Richard Chorbak Pharmacist · Neptune
- Kahkashan Firdaus Physician Assistant - Medical · Clifton
- Chanakya Jandhyala, MD Orthopaedic Surgery · Toms River
- Amanda Kaveney, MD Internal Medicine - Hematology & Oncology · New Brunswick
- Christopher Haydel, MD Orthopaedic Surgery · Medford
- Kelli Danowski, DO Dermatology · Marlton
Mailing Address
211 Essex St, Suite 202
Hackensack, NJ 076013231
Phone: 2014881515